Praveen Kumar Vemula
About Praveen Kumar Vemula
Praveen Kumar Vemula has 8 years in corporate governance. Holds Director role. Currently with 3 companies, including Sepio Health Private Limited and Needel Innovations Private Limited. Formerly with 1 company, such as Sepio Innovations Private Limited. Engaged in Healthcare, General Business and more. Contributes to corporate operations.
Current companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Sepio Health Private Limited
U36900KA2019PTC120477
|
Director | 16 Jan 2019 | 2019 | Active |
|
Needel Innovations Private Limited
U33100KA2022PTC165331
|
Director | 04 Oct 2023 | 2022 | Active |
|
Sturnus Biotech Private Limited
U72100KA2024PTC187364
|
Director | 11 Apr 2024 | 2024 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
|
Sepio Innovations Private Limited
U73200KA2017PTC106479
|
Director | 18 Sep 2017 | 2017 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Praveen Kumar Vemula
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Praveen Kumar Vemula
Praveen Kumar Vemula has 8 years in corporate governance. Holds Director role. Currently with 3 companies, including Sepio Health Private Limited and Needel Innovations Private Limited. Formerly with 1 company, such as Sepio Innovations Private Limited. Engaged in Healthcare, General Business and more. Contributes to corporate operations.
Praveen Kumar Vemula is associated with 3 companies as Director.
Praveen Kumar Vemula has expertise in Healthcare, General Business and other sectors.
Praveen Kumar Vemula has 8 years in corporate governance.